Treatment of anemia in myelodysplastic syndrome with darbepoetin and granulocyte colony stimulating factor [2]

American Journal of Hematology

Volumn 82, Issue 3, 2007, Pages 245-246

  Rose, Shelonitda ^a   Ali, Yaqoob ^a   Maffei, Barbara ^a   Saidi, Parvin ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; BLOOD CELL COUNT; CASE REPORT; CYTOGENETICS; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MONOTHERAPY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS;

AGED; ANEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATINICS; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; TREATMENT OUTCOME;

EID: 33847633523     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20725     Document Type: Letter

References (5)

1. Hussain SI. Myelodysplastic syndromes in the elderly. The role of growth factors in management. Leuk Res 1996;20:203-219.
2. Hellstrom-Lindberg E, Birgegard G, Carlsson M, et al. A combination of granulocyte-colony stimulating factor and erythropoietin may synergistically improve the anemia in patients with myelodysplastic syndromes. Leuk Lymphoma 1993;11:221-228.
3. Musto P, Lanza F, Balleari E, et al. Darbepoetin alpha for the treatment of anemia in low-intermediate risk myelodysplastic syndromes. Br J Hematol 2004;128:204-209.
4. Blinder VS, Robez GJ. Hematopoietic growth factors in myelodysplastic syndromes. Curr Hematol Rep 2003;2:453-458.
5. Jakob A, Hirsch FW, Engelhardt M. Successful treatment of a patient with myelodysplastic syndrome (RAEB) with darbepoetin-alfa in combination with pegfilgrastim. Ann Hematol 2005;84:694-695.